A novel soluble thymosin alpha-1 concatemer showed stronger immunostimulatory activity than monomeric TA1, enhancing T-cell activation and cytokine production — improved manufacturing for enhanced immune therapy.
Key findingA novel soluble thymosin alpha-1 concatemer showed stronger immunostimulatory activity than monomeric TA1, enhancing T-cell activation and cytokine pr
What the researchers found
A novel soluble thymosin alpha-1 concatemer showed stronger immunostimulatory activity than monomeric TA1, enhancing T-cell activation and cytokine production — improved manufacturing for enhanced immune therapy.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2011.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.
International journal of biological sciences, 7(5), 618-28
Citation
Li, Weina; Song, Liqiang; Wu, Shouzhen; Xue, Xiaochang; Zhang, Lu; He, Liqing; Han, Wei; Wang, Qing; Ling, Rui; Zhang, Wei; Yan, Zhen; Zhang, Yingqi. (2011). Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.. International journal of biological sciences, 7(5), 618-28.